FR2444713A1 - PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME - Google Patents

PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME

Info

Publication number
FR2444713A1
FR2444713A1 FR7835588A FR7835588A FR2444713A1 FR 2444713 A1 FR2444713 A1 FR 2444713A1 FR 7835588 A FR7835588 A FR 7835588A FR 7835588 A FR7835588 A FR 7835588A FR 2444713 A1 FR2444713 A1 FR 2444713A1
Authority
FR
France
Prior art keywords
hepatitis
virus
genome
vector
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7835588A
Other languages
French (fr)
Other versions
FR2444713B1 (en
Inventor
Pierre Tiollais
Alex Fritsch
Christiane Pourcel
Patrick Charnay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR7835588A priority Critical patent/FR2444713A1/en
Priority to CH1099879A priority patent/CH646456A5/en
Priority to DE19792950995 priority patent/DE2950995A1/en
Priority to GB7943491A priority patent/GB2034323B/en
Priority to BE2/58277A priority patent/BE880670A/en
Priority to OA56977A priority patent/OA06416A/en
Publication of FR2444713A1 publication Critical patent/FR2444713A1/en
Application granted granted Critical
Publication of FR2444713B1 publication Critical patent/FR2444713B1/fr
Priority to US08/347,162 priority patent/US6225458B1/en
Priority to US08/369,998 priority patent/US6096879A/en
Priority to US08/478,853 priority patent/US6416996B1/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

Procédé de production d'un ADN comprenant le génome caractéristique du virus de l'hépatite B (b1 , b2 ). Il comprend le clonage dans une bactérie d'un ADN double brin formé à partir de l'ADN du virus de l'hépatite B. Application en tant que sonde pour la détection de virus de l'hépatite B dans des sérums.A method of producing a DNA comprising the characteristic genome of hepatitis B virus (b1, b2). It comprises the cloning in bacteria of a double-stranded DNA formed from the DNA of the hepatitis B virus. Application as a probe for the detection of hepatitis B virus in sera.

FR7835588A 1978-12-18 1978-12-18 PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME Granted FR2444713A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR7835588A FR2444713A1 (en) 1978-12-18 1978-12-18 PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME
CH1099879A CH646456A5 (en) 1978-12-18 1979-12-12 METHOD FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME
GB7943491A GB2034323B (en) 1978-12-18 1979-12-18 Production of dna comprising the b hepatitis viral genome
BE2/58277A BE880670A (en) 1978-12-18 1979-12-18 PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME
DE19792950995 DE2950995A1 (en) 1978-12-18 1979-12-18 METHOD FOR PRODUCING A DNA CONTAINING THE HEPATITIS B VIRUS GENOME AND THE VECTOR CONTAINING THIS GENOME
OA56977A OA06416A (en) 1978-12-18 1979-12-18 A method of producing a DNA comprising the genome of the hepatitis B virus and a vector comprising it.
US08/347,162 US6225458B1 (en) 1978-12-18 1994-11-23 Process for the production of DNA comprising the genome of the hepatitis B virus and vector including it
US08/369,998 US6096879A (en) 1978-12-18 1995-01-09 Nucleotide sequence comprising the genome of hepatitis B virus, nucleotide sequence coding the surface antigen of the hepatitis B virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby
US08/478,853 US6416996B1 (en) 1978-12-18 1995-06-07 Nucleotide sequence comprising the genome of hepatitis b virus, nucleotide sequence coding the surface antigen of the hepatitis b virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7835588A FR2444713A1 (en) 1978-12-18 1978-12-18 PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME

Publications (2)

Publication Number Publication Date
FR2444713A1 true FR2444713A1 (en) 1980-07-18
FR2444713B1 FR2444713B1 (en) 1981-02-06

Family

ID=9216265

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7835588A Granted FR2444713A1 (en) 1978-12-18 1978-12-18 PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME

Country Status (6)

Country Link
BE (1) BE880670A (en)
CH (1) CH646456A5 (en)
DE (1) DE2950995A1 (en)
FR (1) FR2444713A1 (en)
GB (1) GB2034323B (en)
OA (1) OA06416A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0020251A2 (en) * 1979-05-24 1980-12-10 The Regents Of The University Of California DNA transfer vector, host transformed with it, vaccine, and their production
FR2560995A1 (en) * 1984-03-07 1985-09-13 Pasteur Institut REAGENTS AND KITS FOR THE QUANTITATIVE DETERMINATION OF A VIRAL NUCLEIC ACID IN A BIOLOGICAL MEDIUM AND METHOD FOR DETERMINING SUCH A VIRAL NUCLEIC ACID
EP0182442A2 (en) * 1978-12-22 1986-05-28 Biogen, Inc. Recombinant DNA molecules and their method of production
EP0374869A1 (en) * 1978-12-22 1990-06-27 Biogen, Inc. Recombinant DNA molecules and their method of production
US5196194A (en) * 1979-05-24 1993-03-23 The Regents Of The University Of California Vaccines containing Hepatitis B S-protein
US6268122B1 (en) 1978-12-22 2001-07-31 Biogen, Inc. Recombinant DNA molecules and their method of production
US6475489B1 (en) 1981-08-04 2002-11-05 The Regents Of The University Of California Synthesis of human virus antigens by yeast

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480779B2 (en) * 1979-08-30 1986-07-18 Anvar VECTOR CONTAINING A NUCLEOTIDE SEQUENCE OF THE SURFACE ANTIGEN OF HEPATITIS B VIRUS AND METHOD FOR MANUFACTURING AN IMMUNOGENIC MOLECULE USING THE SAME
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
EP0038765B1 (en) * 1980-04-22 1987-09-02 Institut Pasteur Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US5145782A (en) * 1980-12-08 1992-09-08 The Regents Of The University Of California DNA expression vector suitable for direct expression of a foreign gene
US4446237A (en) * 1981-03-27 1984-05-01 Life Technologies, Inc. Method for detection of a suspect viral deoxyribonucleic acid in an acellular biological fluid
EP0062286A1 (en) * 1981-03-31 1982-10-13 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic test for hepatitis B virus
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
ZW18282A1 (en) 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
US4803164A (en) * 1981-08-31 1989-02-07 Genentech, Inc. Preparation of hepatitis b surface antigen in yeast
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
FI63596C (en) * 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
US4480040A (en) * 1981-12-03 1984-10-30 The United States Of America As Represented By The Secretary Of Agriculture Sensitive and rapid diagnosis of viroid diseases and viruses
JPS5931799A (en) * 1982-08-16 1984-02-20 Science & Tech Agency Recombinant plasmid and preparation of transformed yeast and hepatitis virus b surface antigen using the same
USRE35491E (en) * 1982-11-04 1997-04-08 The Regents Of The University Of California Methods and compositions for detecting human tumors
US4699877A (en) * 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector
US6607727B1 (en) 1991-08-26 2003-08-19 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
US5780036A (en) * 1991-08-26 1998-07-14 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
ATE199158T1 (en) * 1991-12-23 2001-02-15 Bayer Ag HBV AMPLIFICATION PROBE FOR USE IN SOLUTION STAGE HYBRIDIZATION SANDWICH ASSAY
US6235288B1 (en) 1992-08-26 2001-05-22 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
AU779689B2 (en) 1999-06-16 2005-02-03 Icos Corporation Human poly(ADP-ribose) polymerase 2 materials and methods
AU2002241556B2 (en) 2000-11-01 2007-07-19 Elusys Therapeutics, Inc. Method of producing bispecific molecules by protein trans-splicing
US8247543B2 (en) 2005-04-29 2012-08-21 The Rockefeller University Human microRNAs and methods for inhibiting same
RS51840B (en) 2005-09-01 2012-02-29 Celgene Corporation Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy
ES2466916T3 (en) 2007-06-27 2014-06-11 Admune Therapeutics Llc IL-15 and IL-15R alpha complexes and uses thereof
EP2324044A4 (en) 2008-08-04 2012-04-25 Univ Miami Sting (stimulator of interferon genes), a regulator of innate immune responses
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
US9206440B2 (en) 2009-01-23 2015-12-08 Roger Williams Hospital Viral vectors encoding multiple highly homologus non-viral polypeptides and the use of same
WO2011091435A2 (en) 2010-01-25 2011-07-28 Mount Sinai School Of Medicine Methods of treating liver disease
WO2012151272A2 (en) 2011-05-02 2012-11-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
US9708411B2 (en) 2012-02-16 2017-07-18 The Penn Research Foundation Modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof
JP6359019B2 (en) 2012-10-24 2018-07-18 ノバルティス アーゲー IL-15Rα type, cells expressing IL-15Rα type, and therapeutic use of IL-15Rα and IL-15 / IL-15Rα complex
US10335460B2 (en) 2014-07-29 2019-07-02 Novartis Ag IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions
EP3212770B1 (en) 2014-10-29 2022-06-29 Massachusetts Eye & Ear Infirmary Methods for efficient delivery of therapeutic molecules in vitro and in vivo
US11370823B2 (en) 2014-10-29 2022-06-28 Massachusetts Eye And Ear Infirmary Efficient delivery of therapeutic molecules to cells of the inner ear
CN111315407B (en) 2018-09-11 2023-05-02 上海市公共卫生临床中心 Broad-spectrum anti-influenza vaccine immunogen and application thereof
US11786592B2 (en) 2021-05-19 2023-10-17 The University Of Hong Kong Compositions of cardiolipin adjuvants and methods of use thereof
WO2023077147A2 (en) 2021-11-01 2023-05-04 Pellis Therapeutics, Inc. T-cell vaccines for patients with reduced humoral immunity
WO2023220283A1 (en) 2022-05-12 2023-11-16 Pellis Therapeutics, Inc. Poxvirus adjuvant for t-cell vaccination

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2281426A1 (en) * 1974-08-08 1976-03-05 Ici Ltd PROCESS FOR MODIFICATION OF DESOXY-RIBONUCLEIC ACID AND PRODUCTS OBTAINED
FR2384024A1 (en) * 1977-03-18 1978-10-13 Max Planck Gesellschaft PROCESS FOR PREPARING FILAMENTOUS HYBRID PHAGES, NEW HYBRID PHAGES AND THEIR USE

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2281426A1 (en) * 1974-08-08 1976-03-05 Ici Ltd PROCESS FOR MODIFICATION OF DESOXY-RIBONUCLEIC ACID AND PRODUCTS OBTAINED
FR2384024A1 (en) * 1977-03-18 1978-10-13 Max Planck Gesellschaft PROCESS FOR PREPARING FILAMENTOUS HYBRID PHAGES, NEW HYBRID PHAGES AND THEIR USE

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182442A2 (en) * 1978-12-22 1986-05-28 Biogen, Inc. Recombinant DNA molecules and their method of production
EP0182442A3 (en) * 1978-12-22 1986-10-01 Biogen Nv Recombinant DNA molecules and their method of production.
EP0374869A1 (en) * 1978-12-22 1990-06-27 Biogen, Inc. Recombinant DNA molecules and their method of production
US6268122B1 (en) 1978-12-22 2001-07-31 Biogen, Inc. Recombinant DNA molecules and their method of production
US6270955B1 (en) 1978-12-22 2001-08-07 Biogen, Inc. Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
EP0020251A2 (en) * 1979-05-24 1980-12-10 The Regents Of The University Of California DNA transfer vector, host transformed with it, vaccine, and their production
EP0020251A3 (en) * 1979-05-24 1981-05-20 University California Dna transfer vector, host transformed with it, vaccine, and their production
US5196194A (en) * 1979-05-24 1993-03-23 The Regents Of The University Of California Vaccines containing Hepatitis B S-protein
US6475489B1 (en) 1981-08-04 2002-11-05 The Regents Of The University Of California Synthesis of human virus antigens by yeast
FR2560995A1 (en) * 1984-03-07 1985-09-13 Pasteur Institut REAGENTS AND KITS FOR THE QUANTITATIVE DETERMINATION OF A VIRAL NUCLEIC ACID IN A BIOLOGICAL MEDIUM AND METHOD FOR DETERMINING SUCH A VIRAL NUCLEIC ACID
EP0159223A1 (en) * 1984-03-07 1985-10-23 Institut Pasteur Reagents and kits for the quantitative analysis of a viral nucleic acid in a biological medium and method for the analysis of this viral nucleic acid

Also Published As

Publication number Publication date
DE2950995A1 (en) 1980-07-24
GB2034323B (en) 1983-01-12
DE2950995C2 (en) 1991-05-02
OA06416A (en) 1981-09-30
GB2034323A (en) 1980-06-04
CH646456A5 (en) 1984-11-30
BE880670A (en) 1980-06-18
FR2444713B1 (en) 1981-02-06

Similar Documents

Publication Publication Date Title
FR2444713A1 (en) PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME
Horie et al. Two tRNA1Ile species from an extreme thermophile, Thermus thermophilus HB8: Effect of 2-thiolation of ribothymidine on the thermostability of tRNA
DE507591T1 (en) ANION EXCHANGE OF NUCLEIC ACIDS.
BE875598A (en) METHOD OF DETECTION AND CHARACTERIZATION OF A NUCLEIC ACID OR OF A SEQUENCE OF THE SAME, AND ENZYMATIC REAGENT USED
IT8267522A0 (en) PROCESS FOR THE PRODUCTION OF COMPLEMENTARY DNA REPRESENTING VIRAL RNA SEQUENCES BY RECOMBINANT DNA METHODS RELATED PRODUCTS AND THEIR USES
NO910902D0 (en) METHODS FOR AMPLIFICATION OF A NUCLEIC ACID SEQUENCE USING A TRANSCRIPTION COMPLEX.
DE69432419D1 (en) AN ELECTROCHEMILUMINESCENT DETECTION OF NUCLEIC ACIDS BASED ON THE SELF-SUPPORTING SEQUENCE REPLICATION
ATE41677T1 (en) METHOD OF EXPRESSING A GENE.
ATE85088T1 (en) PROCESS OF ACCELERATED NUCLEIC ACID REASSOCIATION.
DE3588154D1 (en) Faster method for reassociation of nucleic acid
OA05468A (en) Process for obtaining milk-like products from peanuts.
ATE120498T1 (en) NEISSERIA-SPECIFIC DNA PROBE.
DE59309971D1 (en) Specific detection of Neisseria gonorrhoeae
EP0105141A3 (en) Recombinant dna molecules, process for their production, their use for production of hepatitis b surface antigen (hbsag) and pharmaceutical compositions containing this hbsag
FR2443475A1 (en) PROCESS AND APPARATUS FOR DEMONOMIZING POLYCAPRONAMIDE
BE899661A (en) PROCESS FOR INCREASING THE PRODUCTION OF ANTIBIOTICS BY GENETIC RECOMBINATION IN VIVO.
DE3277915D1 (en) Process for the production of hybridisation probes
OA06147A (en) Process for recovering molybdenum from uranium liquors.
DK246481A (en) METHOD FOR PREPARING 2,6-DICHLOR-4-NITROANILIN BY CHLORATION OF P-NITROANILIN
BE888585Q (en) PROCESS FOR THE CHEMICAL STRENGTHENING OF GLASS CONTAINERS USING POTASSIUM SALTS AND NOVEL PRODUCTS THUS OBTAINED,
FR2372153A1 (en) PROCESS FOR OBTAINING PURE L-CYSTINE
DE68910850D1 (en) Process for the production of liquid iron containing chromium.
Fuke Introduction of specific cleavages into RNAs of RNA bacteriophages for determination of base sequences
FR2644461B1 (en) PROCESS FOR STABILIZING THE HYBRIDIZATION OF COMPLEMENTARY POLYNUCLEOTIDE SEQUENCES, PEPTIDE-POLYNUCLEOTIDE CONJUGATES USEFUL FOR THE IMPLEMENTATION OF THE PROCESS
ATE14737T1 (en) PROCESS FOR THE PRODUCTION OF CHLORINE-DIPHENYLPHOSPHANE.